Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Orientation Marketing appoints Sarah Darcy as sales operations executive

May 27, 2025 Marketing Services, Sales and Marketing Corporate, pharmaceutical marketing agency, sales operations executive

Orientation Marketing has announced the appointment of Sarah Darcy as sales operations executive. She joins the business-to-business (B2B) life sciences and …
Appointment

MC2 Therapeutics appoints Trine Ahlgreen as new CEO

May 27, 2025 Research and Development, Sales and Marketing CEO, Corporate, MC2 Therapeutics, Skin, inflammatory skin conditions

MC2 Therapeutics, a Danish pharma company focused on topical therapies for inflammatory skin conditions, has appointed Trine Ahlgreen as CEO. …
Appointment

NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS

May 22, 2025 Market Access, Research and Development Haematology, Hympavzi, NHS, NICE, Pfizer, haemophilia B, marstacimab

Walton Oaks, 21st May 2025 – Pfizer Ltd announced today that the National Institute for Health and Care Excellence (NICE) has published final …
News
Press release

Multiple myeloma treatment approved in Japan

May 21, 2025 Market Access, Research and Development, Sales and Marketing GSK, Japan, Oncology, Orphan Drug Designation (ODD), multiple myeloma

GSK’s Blenrep (belantamab mafodotin) combinations have been approved by Japan’s Ministry of Health, Labour and Welfare for the treatment of …
News

Medable unveils oncology trial platform aimed at reducing logistical hurdles

May 16, 2025 Biotech/start-up, Business Services, Research and Development, Sales and Marketing, Technical Consultancy AI, FDA, Medable, Oncology, digital platform, oncology research, oncology trials

Clinical trial technology provider, Medable, has launched a digital platform designed to support oncology clinical trials by addressing growing operational …
News
shaking-hands-gb7ac17374_1920

Neogap Therapeutics selected to join EIC Soft-landing Programme, supporting international growth

May 15, 2025 Medical Communications, Sales and Marketing Corporate, European Innovation Council (EIC), Immunology, Neogap Therapeutics, US pharma market, biotech, immunotherapy

Swedish biotech company, Neogap Therapeutics, has been selected to participate in the EIC Soft-landing Programme for Healthcare and Life Sciences …
News

Terumo’s plasma donation system adopted by Join Parachute to expand access to lifesaving therapies

May 13, 2025 Biotech/start-up, Sales and Marketing Haematology, Join Parachute, Pharmacy, Terumo Blood and Cell Technologies (Terumo BCT), biotech, plasma donation

US Biotech company, Terumo Blood and Cell Technologies (Terumo BCT), has announced that Join Parachute will adopt its Rika Plasma …
News
bowel_cancer_screening

European Commission approves Johnson & Johnson’s Crohn’s disease therapy

May 12, 2025 Market Access, Research and Development, Sales and Marketing Crohn’s disease, European Commission, Gastrointestinal tract, Johnson & Johnson, guselkumab, marketing authorisation

The European Commission (EC) has granted Marketing Authorisation (MA) to Johnson & Johnson’s Tremfya (guselkumab) for the treatment of moderately …
News
europe-1395916_640

EU approval granted for rare kidney disease treatment

April 29, 2025 Market Access, Research and Development, Sales and Marketing CSL Vifor, EU, Nephrology, Travere Therapeutics, kidney disease, nephrology

The EU has granted marketing authorisation (MA) for Filspari – CSL Vifor and Travere Therapeutics’ therapy for primary IgA nephropathy …
News
blood-75301_640

Sobi and Sanofi’s Foundation S renew partnership with World Federation of Hemophilia

April 28, 2025 Pharmacy sales & educational programmes, Sales and Marketing Haematology, Sanofi, World Federation of Hemophilia, bleeding disorder, sobi

Sobi and Sanofi, through its organisation Foundation S, have extended their partnership with the World Federation of Hemophilia (WFH) Humanitarian …
News

Nordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for European launch

April 14, 2025 Market Access, Research and Development, Sales and Marketing Nordic Pharma, Opthalmology, dry eye disease

International pharma company Nordic Pharma has announced that its Lacrifill treatment for dry eye disease has received European Conformity (CE) …
News

Mehiläinen acquires Regina Maria and MediGroup, and welcomes Hellman & Friedman as new shareholder

April 4, 2025 Business Services, Marketing Services CVC, Corporate, MediGroup, Mehilainen, Regina Maria, shareholders

Mehiläinen, a Finnish health and social care provider, has announced that it has agreed to acquire Regina Maria and MediGroup. …
News
hsm_mobile_clinical_trial_istock-872676342

Medidata launches programme to accelerate therapy delivery

March 31, 2025 Market Research Medidata, Pharmacy, pharma, technology

Medidata has announced the launch of its Medidata Site Insights Program – a collection of initiatives intended to foster more …
News

Gergely Sved appointed as CEO of Ellab

March 28, 2025 Contract Sales Organisations, Sales and Marketing CEO, Ellab, Pharmacy, appointment, life sciences

Ellab has announced that it has appointed Gergely Sved as its new chief executive officer (CEO). The company provides validation, …
Appointment

Carole Imbert appointed as CFO of Vect-Horus

March 28, 2025 Biotech/start-up, Sales and Marketing Pharmacy, Vect-Horus, appointment, biotech, cfo

Vect-Horus has announced it has appointed Carole Imbert as chief financial officer (CFO) and to its executive committee. Vect-Horus is …
Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026